We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+8.31%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$5.17B
AUM Growth
+$808M
Cap. Flow
+$417M
Cap. Flow %
8.07%
Top 10 Hldgs %
16.85%
Holding
722
New
51
Increased
415
Reduced
155
Closed
32

Top Buys

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$43.8M
2
GILD icon
Gilead Sciences
GILD
+$40.8M
3
GE icon
GE Aerospace
GE
+$37.3M
4
MSI icon
Motorola Solutions
MSI
+$24.6M
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$23.3M

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$53.2M
2
AMGN icon
Amgen
AMGN
+$30.4M
3
MJN
Mead Johnson Nutrition Company
MJN
+$21.5M
4
CNI icon
Canadian National Railway
CNI
+$20.9M
5
BDX icon
Becton Dickinson
BDX
+$18M

Sector Composition

Rank Sector Weight
1 Healthcare 24.05%
2 Financials 13.76%
3 Technology 12.91%
4 Communication Services 9.31%
5 Industrials 8.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALL icon
26
Allstate
ALL
$66.5B
$31.8M 0.61%
389,638
-1,574
-0.4% -$124K
PM icon
27
Philip Morris
PM
$302B
$30.8M 0.6%
273,078
-44,765
-14% -$4.62M
BRK.B icon
28
Berkshire Hathaway Class B
BRK.B
$1.07T
$29.5M 0.57%
176,816
+32,359
+22% +$5.41M
ABBV icon
29
AbbVie
ABBV
$458B
$29.4M 0.57%
450,934
+221,678
+97% +$13.9M
CPB icon
30
Campbell Soup
CPB
$6.47B
$28.3M 0.55%
493,583
+53,849
+12% +$3.26M
ABT icon
31
Abbott
ABT
$180B
$27.8M 0.54%
625,064
+196,395
+46% +$8.49M
UNH icon
32
UnitedHealth
UNH
$381B
$27.6M 0.53%
168,372
+21,943
+15% +$3.59M
C icon
33
Citigroup
C
$221B
$27.6M 0.53%
460,859
-9,399
-2% -$556K
TRV icon
34
Travelers Companies
TRV
$80.6B
$27.3M 0.53%
226,278
-5,396
-2% -$649K
WFC icon
35
Wells Fargo
WFC
$261B
$27M 0.52%
485,901
+64,742
+15% +$3.67M
MSI icon
36
Motorola Solutions
MSI
$68.3B
$26.8M 0.52%
310,699
+301,326
+3,215% +$24.6M
CL icon
37
Colgate-Palmolive
CL
$72.3B
$25.4M 0.49%
347,505
+154,785
+80% +$10.8M
VRTX icon
38
Vertex Pharmaceuticals
VRTX
$122B
$25.4M 0.49%
232,567
-24,851
-10% -$2.19M
ALXN
39
DELISTED
Alexion Pharmaceuticals
ALXN
$25.4M 0.49%
209,397
+15,797
+8% +$2.04M
QCOM icon
40
Qualcomm
QCOM
$178B
$23.7M 0.46%
413,309
+35,579
+9% +$2.06M
CRM icon
41
Salesforce
CRM
$133B
$23.7M 0.46%
285,982
+10,297
+4% +$823K
MO icon
42
Altria Group
MO
$121B
$23.3M 0.45%
326,615
+119,574
+58% +$8.65M
CVX icon
43
Chevron
CVX
$388B
$22.5M 0.44%
209,983
-30,218
-13% -$3.39M
AMAT icon
44
Applied Materials
AMAT
$435B
$22.5M 0.44%
578,129
-190,772
-25% -$6.85M
HIG icon
45
Hartford Financial Services
HIG
$38.4B
$22.2M 0.43%
461,867
+154,396
+50% +$7.47M
DGX icon
46
Quest Diagnostics
DGX
$25.1B
$21.8M 0.42%
221,601
+153,816
+227% +$14.7M
ROK icon
47
Rockwell Automation
ROK
$51.6B
$21.5M 0.42%
138,244
+126,122
+1,040% +$18.8M
UNM icon
48
Unum
UNM
$13.8B
$21.5M 0.42%
457,989
+149,488
+48% +$7M
SLB icon
49
SLB Ltd
SLB
$78B
$21.4M 0.41%
273,890
+6,546
+2% +$535K
DFS
50
DELISTED
Discover Financial Services
DFS
$21.3M 0.41%
311,258
+54,212
+21% +$3.81M
1
2
3 4 5

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q1 2017 Portfolio in Review

As of Q1 2017, Candriam SCA held 722 positions worth $5.17B, up 19% from $4.36B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Candriam SCA deployed $417M of net new capital in Q1 2017, opening 51 new positions and adding to 415 existing holdings. Its largest new stake was Copart: 1,499,296 shares worth $11.6M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 24% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Johnson & Johnson, an estimated $53.2M trimmed.

  • Candriam SCA's largest Q1 2017 buy was Copart: 1,499,296 shares worth $11.6M.
  • Candriam SCA added most to Celgene Corp in Q1 2017, an estimated $43.8M increase.
  • Candriam SCA's biggest Q1 2017 reduction was Johnson & Johnson, cutting an estimated $53.2M.
  • Candriam SCA fully exited TechnipFMC in Q1 2017, selling an estimated $7.64M.
  • Candriam SCA's ten largest holdings make up 17% of its $5.17B portfolio in Q1 2017.
  • Candriam SCA opened 51 new positions and closed 32 in Q1 2017.
  • Candriam SCA's portfolio value rose 19% quarter-over-quarter to $5.17B.

Based on Candriam SCA's 13F filing for Q1 2017, filed 21 Apr 2017.